Journal of Clinical Endocrinology & Metabolism, Vol 75, 195-200, Copyright © 1992 by Endocrine Society

ARTICLES

Measurement of estradiol-17-fatty acid esters in human tissues

JM Larner, CH Shackleton, E Roitman, PE Schwartz and RB Hochberg
Yale University Medical School, Department of Obstetrics and Gynecology, New Haven, Connecticut 06510.

We have developed a gas chromatographic/mass spectral method for the sensitive and reproducible measurement of estradiol-17-fatty acid esters in human tissues and blood. To provide an internal standard for quantification, a trideuterated analog of a representative estradiol ester is added to the tissues. Estradiol (E2) released from the nonpolar ester fraction by alkaline hydrolysis is derivatized to form the ditrimethylsilyl ether and then analyzed by gas chromatographic/mass spectral, monitoring the molecular ions mass per U charge of the ditrimethylsilyl derivative of E2 and [2H3]E2. There are low but detectable levels of E2 ester in the blood of cycling females; there are none in urine. While the E2 ester is present in breast cyst fluid, its concentration, 77-140 pmol/L, is considerably less than E2, 110-2,863 pmol/L. But there is a large amount of E2 ester in fat. In premenopausal women the average E2 ester in fat (sc and omental) is 957 +/- 283 38 fmol/g (SEM); in women who are menopausal less than 12 yr, the E2 ester in fat is 669 +/- 158 fmol/g; in women who are menopausal at least 15 yr, the fat level is 399 +/- 146 fmol/g. Muscle from the same women have lower concentrations of the ester; in 8 out of 12 muscle specimens it was not detectable. The E2 esters are extremely potent estrogens. Although they are hormonally active they require enzymatic hydrolysis to exert their hormonal action. These studies show that these long chain esters of E2 are sequestered in fatty tissues, wherein they represent a protected store of preformed hormone. Under the proper stimulation, adipose tissue can activate the estrogenic signal through the action of hormonally sensitive esterases. Thus, through signaling between estrogen sensitive tissues and neighboring fat cells, a local paracrine loop may exist.

This article has been cited by other articles:

				R. T. Falk, E. Gentzschein, F. Z. Stanczyk, L. A. Brinton, M. Garcia-Closas, O. B. Ioffe, and M. E. Sherman Measurement of Sex Steroid Hormones in Breast Adipocytes: Methods and Implications Cancer Epidemiol. Biomarkers Prev., August 1, 2008; 17(8): 1891 - 1895. [Abstract] [Full Text] [PDF]

				M. Badeau, V. Vihma, T. S. Mikkola, A. Tiitinen, and M. J. Tikkanen Estradiol Fatty Acid Esters in Adipose Tissue and Serum of Pregnant and Pre- and Postmenopausal Women J. Clin. Endocrinol. Metab., November 1, 2007; 92(11): 4327 - 4331. [Abstract] [Full Text] [PDF]

				M. S. Spagnuolo, L. Cigliano, L. D. D'Andrea, C. Pedone, and P. Abrescia Assignment of the Binding Site for Haptoglobin on Apolipoprotein A-I J. Biol. Chem., January 14, 2005; 280(2): 1193 - 1198. [Abstract] [Full Text] [PDF]

				V. Vihma, A. Tiitinen, O. Ylikorkala, and M. J. Tikkanen Quantitative Determination of Estradiol Fatty Acid Esters in Lipoprotein Fractions in Human Blood J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2552 - 2555. [Abstract] [Full Text] [PDF]

				V. Vihma, S. Vehkavaara, H. Yki-Jarvinen, H. Hohtari, and M. J. Tikkanen Differential Effects of Oral and Transdermal Estradiol Treatment on Circulating Estradiol Fatty Acid Ester Concentrations in Postmenopausal Women J. Clin. Endocrinol. Metab., February 1, 2003; 88(2): 588 - 593. [Abstract] [Full Text] [PDF]

				M. Saadatian-Elahi, P. Toniolo, P. Ferrari, J. Goudable, A. Akhmedkhanov, A. Zeleniuch-Jacquotte, and E. Riboli Serum Fatty Acids and Risk of Breast Cancer in a Nested Case-Control Study of the New York University Women's Health Study Cancer Epidemiol. Biomarkers Prev., November 1, 2002; 11(11): 1353 - 1360. [Abstract] [Full Text] [PDF]

				M. J Tikkanen, V. Vihma, M. Jauhiainen, A. Hockerstedt, H. Helisten, and M. Kaamanen Lipoprotein-associated estrogens Cardiovasc Res, November 1, 2002; 56(2): 184 - 188. [Abstract] [Full Text] [PDF]

				V. Vihma, H. Adlercreutz, A. Tiitinen, P. Kiuru, K. Wahala, and M. J. Tikkanen Quantitative Determination of Estradiol Fatty Acid Esters in Human Pregnancy Serum and Ovarian Follicular Fluid Clin. Chem., July 1, 2001; 47(7): 1256 - 1262. [Abstract] [Full Text] [PDF]

				S. Xu, B. T. Zhu, M. X. Cai, and A. H. Conney Stimulatory Effect of Clofibrate on the Action of Estradiol in the Mammary Gland but Not in the Uterus of Rats J. Pharmacol. Exp. Ther., April 1, 2001; 297(1): 50 - 56. [Abstract] [Full Text]

				S. S. Kanji, W. Kuohung, D. C. Labaree, and R. B. Hochberg Regiospecific Esterification of Estrogens by Lecithin:Cholesterol Acyltransferase J. Clin. Endocrinol. Metab., July 1, 1999; 84(7): 2481 - 2488. [Abstract] [Full Text]

				R. B. Hochberg Biological Esterification of Steroids Endocr. Rev., June 1, 1998; 19(3): 331 - 348. [Abstract] [Full Text]

				G. T. Shwaery, J. A. Vita, and J. F. Keaney Jr Antioxidant Protection of LDL by Physiological Concentrations of 17ß-Estradiol : Requirement for Estradiol Modification Circulation, March 18, 1997; 95(6): 1378 - 1385. [Abstract] [Full Text]